Allergy Shot: The Complete SCIT Guide for Patients
An allergy shot is subcutaneous immunotherapy (SCIT) — a 3-to-5-year course of injected allergen extracts that reduces allergy symptoms by a pooled SMD of -0.73 across 51 RCTs (Calderón 2007 Cochrane). Most people expect a one-time fix; the AAAAI/ACAAI Practice Parameter (Cox 2011) defines SCIT as 24-28 weekly build-up visits followed by years of maintenance injections every 2-4 weeks.
7 peer-reviewed sources
An allergy shot is subcutaneous immunotherapy (SCIT), a multi-year course of injected allergen extracts that modifies the underlying immune response — not a one-time treatment or a vaccine in the infectious-disease sense.
The essentials
An allergy shot is the patient-facing lay term for subcutaneous immunotherapy (SCIT) — the same procedure defined in the AAAAI/ACAAI/JCAAI Practice Parameter Third Update (Cox L, Nelson H, Lockey R et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1-S55, DOI 10.1016/j.jaci.2010.09.034). One allergy shot is a single administration of FDA-licensed allergenic extract, delivered subcutaneously into the upper outer arm — but it is only meaningful as one step in a 3-to-5-year course.
Three common misconceptions deserve direct correction before anything else. First, one shot is not a treatment — the immune system requires a sustained dose-escalation schedule to retrain. Conventional build-up involves 1-2 injections per week for 3-6 months (approximately 24-28 visits), escalating from roughly 0.05 mL of the most dilute vial to approximately 0.5 mL of the maintenance concentrate. Maintenance then continues every 2-4 weeks for 3-5 years. Second, the injection is not a vaccine in the infectious-disease sense — SCIT uses allergen extract to induce immune tolerance, not to generate neutralizing antibodies against a pathogen. Third, the injection given once at a primary-care visit is almost always either a depot corticosteroid (Kenalog-40, Depo-Medrol) or rescue epinephrine — neither is allergen immunotherapy.
The hardware is highly standardized per Cox 2011: a 1-mL tuberculin syringe, a 26G or 27G half-inch needle, subcutaneous administration over the posterolateral upper outer arm, with arms alternated each visit. After every injection, a mandatory 30-minute observation period applies — approximately 70% of fatal or near-fatal systemic reactions begin within that window (Cox 2011 Summary Statement 32).
Curex pairs an at-home IgE blood test with allergist review to identify which allergens are actually driving symptoms before any immunotherapy plan is built, so patients don't enter a 3-to-5-year course aimed at the wrong target.
SCIT is indicated for IgE-mediated allergic rhinitis, allergic conjunctivitis, allergic asthma, and Hymenoptera venom hypersensitivity. The 19 FDA-standardized extracts span 8 grass pollens, short ragweed, cat hair and cat pelt, two house dust mite species, and five Hymenoptera venoms. All other extracts are non-standardized, labeled in PNU/mL or w/v.
How allergy shots retrain your immune system
SCIT retrains immune cells by repeatedly exposing them to escalating doses of the specific allergen driving symptoms. The core shift is from Th2 inflammatory responses (which produce IgE and drive allergic reactions) toward regulatory T-cell-mediated tolerance. This is not immune suppression — it is immune reprogramming targeted at the exact sensitization confirmed by testing.
IgE Sensitization Confirmed
Before any injection is administered, a board-certified allergist confirms IgE sensitization via skin prick test (wheal ≥3 mm above negative control) or specific IgE blood test (≥0.35 kUA/L). Only confirmed sensitizations are included in the custom vial. This step prevents treating the wrong allergen over a 3-to-5-year course.
Build-Up: Escalating Doses Reprogram Early Immunity
Within hours of the first injections, histamine receptor 2 is upregulated on basophils, suppressing immediate allergic degranulation. Over 24-28 weekly visits, dose volume rises from 0.05 mL of the most dilute vial to approximately 0.5 mL of the maintenance concentrate. The mandatory 30-minute observation window after each injection is required because most systemic reactions begin within that period.
Regulatory T Cells Expand
Between 2 and 4 weeks into build-up, FOXP3+ CD25+ Tregs and IL-10-producing Tr1 cells become detectable. These cells produce anti-inflammatory cytokines (IL-10, TGF-beta) that suppress Th2 responses and promote IgE-to-IgG4 class-switching. Allergen-specific IgG4 rises measurably within 1-3 months and continues rising through maintenance.
Maintenance: Durable Tolerance Consolidates
IgG4 blocking antibodies — 10 to 100-fold higher than pre-treatment levels — compete with IgE for allergen binding, preventing mast cell degranulation and the allergic cascade. After 3-5 years of maintenance, long-lived plasma cells in bone marrow niches continue producing IgG4 even after treatment stops, explaining the years-long persistence of benefit confirmed by Durham 1999 NEJM.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The allergy shot timeline divides into three stages with distinct frequency requirements. Understanding the full schedule before starting is critical — the 43.9% maintenance-completion rate in real-world data (Tkacz 2021) reflects how many patients underestimate the commitment.
Conventional build-up runs approximately 24-28 weekly visits to reach the maintenance dose. Cluster protocols (2-4 injections per visit at 30-minute intervals) can compress build-up to 4-8 weeks (Tabar AI et al., J Allergy Clin Immunol 2005;116:109-118) but carry higher per-injection systemic-reaction risk. Rush protocols (1-3 days) are available at specialized centers with pre-medication. A 30-minute observation follows every injection regardless of schedule.
Once the therapeutic maintenance dose is reached, injection frequency drops to every 2-4 weeks. The 30-minute observation period applies at every maintenance visit. Gaps of more than 3-4 months typically require restarting build-up from an earlier dilution. Disease benefits accumulate progressively — most patients notice meaningful improvement within 3-6 months of reaching maintenance.
After completing a 3-5 year course, disease-modifying benefits persist for an average of 3-12 years without further injections, per Durham SR et al. (N Engl J Med 1999;341:468-475). Children who complete SCIT courses have a significantly reduced risk of developing asthma at 10-year follow-up (Jacobsen L et al., Allergy 2007 PAT study, OR 4.6). Patients experiencing return of symptoms after several years may discuss re-treatment with their allergist.
Efficacy by allergen — what the data shows
The evidence base for allergy shots is among the strongest in allergy medicine. Cochrane meta-analysis of grass-pollen SCIT (Calderón MA et al., Cochrane Database Syst Rev 2007, DOI 10.1002/14651858.CD001936.pub2) across 51 RCTs and 2,871 patients found a symptom score SMD of -0.73 (95% CI -0.97 to -0.50) and a medication score SMD of -0.57. These are clinically meaningful reductions that persist after treatment stops — a property pharmacotherapy does not share.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Allergy shots occupy a unique position among allergy treatments because they are the only option proven to modify the underlying immune disease. The main alternatives differ in mechanism, delivery, and disease-modifying potential.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
Allergy Shots (SCIT) | |||||
SLIT Drops | |||||
SLIT Tablets (Grastek/Oralair/Ragwitek/Odactra) | |||||
Antihistamines + Intranasal Steroids |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
Curex delivers allergist-prescribed SCIT — the allergy shot itself — at home for $129/month, with no clinic visits and no facility fees. The personalized serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector is confirmed on hand before your first dose, and your first injection and every dose change are supervised live over Zoom by the prescribing physician.
See if at-home shots are right for youSide effects — what to watch for
Every allergy shot is given in a medical office because of the small but real risk of systemic allergic reactions, including anaphylaxis. The mandatory 30-minute post-injection observation is not optional — approximately 70% of serious reactions begin within that window. Safety surveillance across 23.3 million US injection visits (2008-2012) recorded one confirmed fatality (Epstein TG et al., Ann Allergy Asthma Immunol 2013, PMID 23535092).
Frequently asked questions
What is an allergy shot, exactly?
An allergy shot is subcutaneous immunotherapy (SCIT) — a custom-compounded preparation of FDA-licensed allergen extract injected under the skin of the upper outer arm. It is not a vaccine against infectious disease and not a one-time treatment. The full course runs 3-5 years: a build-up phase of approximately 24-28 weekly injections escalating from 0.05 mL to 0.5 mL of the maintenance concentrate, followed by maintenance injections every 2-4 weeks. Each visit requires a mandatory 30-minute observation period per Cox 2011 Practice Parameter (DOI 10.1016/j.jaci.2010.09.034), because most serious reactions occur within that window.
How long does it take for allergy shots to work?
Most patients notice meaningful symptom improvement within 3-6 months of reaching the maintenance dose, though disease-modifying benefits require completing the full 3-5 year course. Cochrane meta-analysis (Calderón 2007, 51 RCTs / 2,871 patients) found a symptom SMD of -0.73 and medication SMD of -0.57 — clinically meaningful reductions. Durham SR et al. (N Engl J Med 1999;341:468-475) demonstrated that benefits persist for years after a 3-4 year grass-pollen SCIT course ends. Real-world data (Tkacz 2021) show only 43.9% of initiators reach maintenance, so the completion rate is the primary predictor of outcome.
Do allergy shots hurt?
Most patients describe the injection as a brief pinch similar to a blood draw. The 26G or 27G half-inch needle used for SCIT (per Cox 2011 and the ACAAI Extract Preparation Guide) is narrow and short. The injection goes into the subcutaneous fat of the upper outer arm — not intramuscular — which reduces the pain associated with deeper injections. Local redness, mild swelling, and itching at the injection site occur in approximately 16.3% of injections and are expected immune-activation responses, not signs of a problem. Most patients find the 30-minute observation wait after the injection more inconvenient than the injection itself.
Can allergy shots cause anaphylaxis?
Yes — anaphylaxis is a rare but real risk, which is why every allergy shot is given in a medical office with epinephrine available. Surveillance data across 23.3 million US injection visits (2008-2012) recorded one confirmed fatality (Epstein TG et al., PMID 23535092). Systemic reactions overall occur in approximately 0.1% of injection visits. The WAO grades systemic reactions on a 5-scale system (Cox L et al., J Allergy Clin Immunol 2010;125:569-574). Major risk factors include uncontrolled asthma, a previous systemic reaction, and dosing during peak pollen season. The 30-minute observation period captures approximately 70% of serious reactions before the patient leaves the office.
Who qualifies for allergy shots?
Allergy shots are appropriate for patients with IgE-confirmed sensitization (positive skin prick test or specific IgE ≥0.35 kUA/L) whose symptoms correlate with their sensitization and who have not achieved adequate control with pharmacotherapy alone. Per Cox 2011 Practice Parameter, SCIT is indicated for allergic rhinitis, allergic conjunctivitis, allergic asthma (if FEV1 is adequately controlled), and Hymenoptera venom hypersensitivity. Absolute contraindications include severe or uncontrolled asthma (FEV1 below 70% predicted on the day of injection), use of beta-blockers, and severe cardiovascular disease. Initiation is not recommended during pregnancy, though continuation of established maintenance may be considered with allergist supervision.
What is the difference between an allergy shot and a Kenalog shot?
Allergy shots (SCIT) and Kenalog shots (triamcinolone acetonide depot corticosteroid) are completely different drug classes. SCIT delivers FDA-licensed allergen extract to induce immune tolerance over a 3-5 year course — it is disease-modifying and has no steroid. Kenalog-40 is an intramuscular or intraarticular depot corticosteroid that suppresses the inflammatory response symptomatically for several days to weeks; it does not modify the underlying allergic disease. The AAAAI/ACAAI Joint Task Force rhinitis practice parameter discourages routine use of injectable corticosteroids for allergic rhinitis and contraindicates recurrent administration due to HPA-axis suppression risk.
How many allergy shots do you need?
A conventional SCIT course involves approximately 60-80+ injection visits over 3-5 years. The build-up phase accounts for roughly 24-28 visits over 3-6 months (1-2 per week). Maintenance visits then occur every 2-4 weeks for 3-5 years, adding 36-90+ additional visits depending on the course length. Cluster protocols compress build-up to 4-8 weeks by giving 2-4 injections per visit (Tabar AI et al., JACI 2005;116:109-118). Rush protocols complete build-up in 1-3 days. For conventional build-up, the AAAAI/ACAAI surveillance data align with CMS LCD L36240, which specifies the typical build-up period as 3-6 months.
Are allergy shots covered by insurance?
Most commercial insurance plans cover allergy shots under the major medical benefit, not the pharmacy benefit. The three core billing codes are CPT 95115 (single injection administration), CPT 95117 (two or more injections per visit), and CPT 95165 (vial preparation per dose), per CMS Article A57472. Medicare Part B covers medically necessary allergy immunotherapy when ordered by a physician. Coverage terms differ by plan — deductibles, copays, and authorization requirements vary. A meaningful complication is practice-setting billing: the same injection billed in a hospital outpatient department (HOPD) may carry a facility fee of hundreds of dollars beyond the professional-service fee that would apply at a standalone allergist office.
Related Articles
Allergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Shot for Dog Allergies | Curex Human SCIT Guide
Yes, there is an allergy shot for humans allergic to dogs — but dog SCIT evidence is 'poor and conflicting.' 16.5% of patients may skip shots if Can f 5-monosensitized.
Read moreAllergy Shot Therapy: SCIT as Disease-Modifying Care | Curex
Allergy shot therapy (SCIT) is the only disease-modifying allergy therapy per Cox/Murphey/Hankin 2020. Cochrane 2007: symptom SMD -0.73 across 51 RCTs. Learn the course.
Read moreCat Allergy Shots for Humans | Curex SCIT Guide
Cat allergy shots for humans traditionally mean ~95–119 clinic visits over 3–5 years (23.9% quit, Tkacz 2021). Curex delivers that SCIT at home, $129/mo.
Read moreAnti-Allergy Shot: SCIT vs Xolair vs Steroids vs EpiPen | Curex
Anti-allergy shot covers SCIT (allergen extract), Xolair, Dupixent, Tezspire, depot steroids, and epinephrine. Only SCIT is disease-modifying. Disambiguation matrix with FDA citations.
Read moreAllergy Medicine Shot: SCIT vs Xolair vs Steroids | Curex
Allergy medicine shots include SCIT (allergen extract, not a drug), Xolair, Dupixent, and depot steroids. Only SCIT modifies disease. AAAAI discourages routine steroid shots.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.